← Back to Treatments
🏅 FDA Orphan Designation

M.V.I.-12

multi-vitamin infusion without vitamin K

Manufacturer: Mayne Pharma (USA) Inc.

Indicated for:
Chromomycosis

FDA-Approved Indications (1)

Prevention of thromboembolic complications in people receiving home parenteral nutrition who also receive warfarin-type anticoagulant therapy

Population: people receiving home parenteral nutrition

Indications & Usage

Prevention of vitamin deficiency and thrombormbolic complications in people receiving home parenteral nutrition who also receive warfarin-type anticoagulant therapy

💙 Support Programs

View all →
M.V.I.-12
Mayne Pharma (USA) Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.